F. Hoffmann-La Roche Ltd.

In News

Roche to present new data advancing its obesity portfolio - GlobeNewswire

GlobeNewswire - Jun 01, 2026

FDA accepts New Drug Application for Roche’s giredestrant in ER-positive early-stage breast cancer, the first and only oral SERD with positive phase III results in the curative setting - Yahoo Finance UK

Yahoo Finance UK - Jun 02, 2026

Roche to acquire Pathai for up to $1.05B - BioWorld News

BioWorld News - May 07, 2026

China's Hansoh signs up to $1.45 billion deal for colorectal cancer drug with Roche - Reuters

Reuters - Oct 16, 2025

Roche to launch global study of Elevidys following EU rejection - Clinical Trials Arena

Clinical Trials Arena - Apr 17, 2026

Roche receives CE mark for new blood test to detect - GlobeNewswire

GlobeNewswire - May 12, 2026

Change to the Roche Enlarged Corporate Executive Committee - Yahoo Finance

Yahoo Finance - Feb 16, 2026

Roche to present new data at ASCO 2026, reinforcing - GlobeNewswire

GlobeNewswire - May 19, 2026

Roche launches the Liver Disease Panel, the first suite of certified algorithms to support Chronic Liver Disease management - Yahoo Finance UK

Yahoo Finance UK - May 26, 2026

[Ad hoc announcement pursuant to Art. 53 LR] Roche reports - GlobeNewswire

GlobeNewswire - Apr 23, 2026

Roche inaugurates new research home for the Institute of Human Biology, pioneering human model systems to accelerate drug discovery and development - Yahoo Finance

Yahoo Finance - Mar 23, 2026

Roche enters into a definitive merger agreement to acquire PathAI to transform AI-driven diagnostics - GlobeNewswire

GlobeNewswire - May 07, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment